Keros Therapeutics (KROS) Tops Q4 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: KROS) | Delayed: 11.28 -0.07 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.35 | 52 Week High | $ | |||
| Open | $11.28 | 52 Week Low | $ | |||
| Day High | $11.34 | P/E | N/A | |||
| Day Low | $10.92 | EPS | $ | |||
| Volume | 120,901 | |||||
